Human papillomavirus (HPV) is closely associated with cervical cancer that the incidence of
this tumor is regarded as a surrogate marker for HPV infection in countries lacking …

Introduction: Although human papillomavirus (HPV) routine vaccination programmes have
been implemented around the world and recommendations have been expanded to include …

The policy recommends cytology-based screening every three years from 25 to 30 years of
age, followed by HPV-based screening every five years from 30 to 65 years of age (Exhibit …

Objective The aim of the study was to evaluate the efficacy of Papilocare, a Coriolus
versicolor–based vaginal gel, in repairing human papillomavirus (HPV)-related low-grade …

The incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing in
some regions. Nevertheless, the epidemiology of this disease has not been extensively …

La infección por el virus del papiloma humano (VPH) es la infección de transmisión sexual
más frecuente en el mundo. Este virus ocasiona generalmente lesiones benignas, como …

Background The new nine-valent vaccine against human papillomavirus (HPV) includes the
four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV …

Background The aims of this study were to detect HPV E6/E7 mRNA expression in women
with high-risk genotypes (HPV-16,-18,-31,-33 and-45) analysing its relationship with tissue …

Frequency of cervical cancer related to Human Papilloma Virus (HPV) has increased
remarkably in less-developed countries. Hence, applying capable diagnostic methods is …

Objetivo Estimar la asociación entre la vacunación frente al virus papiloma humano (VPH) y
las conductas sexuales de riesgo, así como la participación en el Programa de Detección …